ST7L and breast cancer: Wang et al. [34] first demonstrated that the expression of the suppression of tumorigenicity 7 like (ST7L) is downregulated in BC cells, and more importantly, that ST7L acts as an antitumor supervisor by reducing GSK-3β phosphorylation and inducing β-catenin degradation.